Matches in Wikidata for { <http://www.wikidata.org/entity/Q37177646> ?p ?o ?g. }
- Q37177646 description "article científic" @default.
- Q37177646 description "article scientifique" @default.
- Q37177646 description "articolo scientifico" @default.
- Q37177646 description "artigo científico" @default.
- Q37177646 description "artículu científicu espublizáu en 2016" @default.
- Q37177646 description "bilimsel makale" @default.
- Q37177646 description "scientific article published on 09 August 2016" @default.
- Q37177646 description "vedecký článok" @default.
- Q37177646 description "vetenskaplig artikel" @default.
- Q37177646 description "videnskabelig artikel" @default.
- Q37177646 description "vědecký článek" @default.
- Q37177646 description "wetenschappelijk artikel" @default.
- Q37177646 description "wissenschaftlicher Artikel" @default.
- Q37177646 description "наукова стаття, опублікована в серпні 2016" @default.
- Q37177646 description "научни чланак" @default.
- Q37177646 description "مقالة علمية نشرت في 09 أغسطس 2016" @default.
- Q37177646 name "Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)." @default.
- Q37177646 name "Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)." @default.
- Q37177646 name "Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study" @default.
- Q37177646 type Item @default.
- Q37177646 label "Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)." @default.
- Q37177646 label "Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)." @default.
- Q37177646 label "Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study" @default.
- Q37177646 prefLabel "Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)." @default.
- Q37177646 prefLabel "Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)." @default.
- Q37177646 prefLabel "Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study" @default.
- Q37177646 P1433 Q37177646-AF535DA6-CCEF-49B3-8506-ACC628BCFDC7 @default.
- Q37177646 P1476 Q37177646-ACBEA5A2-3FBC-44A7-B495-1B165734C4B9 @default.
- Q37177646 P2093 Q37177646-00264FE7-8571-4A03-948F-7F95533FBEEB @default.
- Q37177646 P2093 Q37177646-1A52EE4B-9199-4C7C-B1C9-253C8831F89C @default.
- Q37177646 P2093 Q37177646-265CD940-DD67-4954-99D8-4DBBA87E8A2B @default.
- Q37177646 P2093 Q37177646-72B5EDE8-33F5-4671-8C0C-513CA2BDB817 @default.
- Q37177646 P2093 Q37177646-871C6793-CB7B-4066-9D92-23F3945ED40B @default.
- Q37177646 P2093 Q37177646-8FE09BE3-69D8-498E-BCB2-893D99246528 @default.
- Q37177646 P2093 Q37177646-CA6F7B6A-C735-4FB3-9813-1E20CED45B82 @default.
- Q37177646 P2093 Q37177646-DE4B55B2-5D96-47DF-985E-27DD9D7E36AE @default.
- Q37177646 P2860 Q37177646-1026DB41-2263-47E7-9AC7-31A2DC0F4CAA @default.
- Q37177646 P2860 Q37177646-12A7E9FF-15E5-442B-9105-ED0313DEE58E @default.
- Q37177646 P2860 Q37177646-16991FC1-1679-46AF-A12F-93FADDE69353 @default.
- Q37177646 P2860 Q37177646-223D312E-4149-48D3-A94C-505270E2BFBC @default.
- Q37177646 P2860 Q37177646-2B60B9A5-6DF9-4BF8-AD33-857AB88BA88A @default.
- Q37177646 P2860 Q37177646-31839DAB-D6C3-4FA6-8DE5-3DC21E9575D2 @default.
- Q37177646 P2860 Q37177646-470F2A37-D05B-4DF9-BBC6-840AE060E9EF @default.
- Q37177646 P2860 Q37177646-480058F3-46C1-46DB-8D6D-EB9A97169970 @default.
- Q37177646 P2860 Q37177646-59235983-6883-426C-9CED-923DF55240E6 @default.
- Q37177646 P2860 Q37177646-5FBC7B7F-A84A-4AAF-AD3D-E1FE9E0C12CF @default.
- Q37177646 P2860 Q37177646-6578BF9C-9FA5-406F-86A2-CBCB29C38A9A @default.
- Q37177646 P2860 Q37177646-7BCB52B5-BED5-4F2A-8F89-ED73711DD3ED @default.
- Q37177646 P2860 Q37177646-827E872F-4274-46E5-8866-1CDFCFF440F6 @default.
- Q37177646 P2860 Q37177646-877D55BB-F5DB-459D-BB02-40CEAECCC098 @default.
- Q37177646 P2860 Q37177646-886B769D-EED0-40AF-AEE5-FCB75A5AD0AD @default.
- Q37177646 P2860 Q37177646-94AC84CB-D295-4859-ACA4-B885BAB9C708 @default.
- Q37177646 P2860 Q37177646-A6D4F99C-E6D1-408B-A4C5-0766E8CB28A8 @default.
- Q37177646 P2860 Q37177646-B1DEBC37-E9FF-4D0C-98D1-B7A549D9AE34 @default.
- Q37177646 P2860 Q37177646-C0180246-0A79-4A41-9226-D696575C9CFC @default.
- Q37177646 P2860 Q37177646-C38DD8B3-3CF5-4DD3-92A7-CF4F8D49AEEB @default.
- Q37177646 P2860 Q37177646-D64C0C58-CF4C-4842-8D4D-A3E89F2CB8B6 @default.
- Q37177646 P2860 Q37177646-E5858C53-A36A-430F-995B-E8F28088FF02 @default.
- Q37177646 P2860 Q37177646-FA29F163-656D-4828-8844-8B9895B7D782 @default.
- Q37177646 P304 Q37177646-A0BAF103-1C6D-4788-8CF9-7297EAC1049A @default.
- Q37177646 P31 Q37177646-BD3505BD-F52B-415D-9577-41D0726A717B @default.
- Q37177646 P356 Q37177646-D50F75AD-29E9-4644-8187-D100A7583BC1 @default.
- Q37177646 P433 Q37177646-BCBAAC58-5A4D-4EAA-A83B-8DBF0C1E21B4 @default.
- Q37177646 P478 Q37177646-C60342E6-02D4-413F-A64D-D524ECA356FF @default.
- Q37177646 P50 Q37177646-5F4B1B0D-765A-4885-A84F-BD53B3B5ADE4 @default.
- Q37177646 P577 Q37177646-964FE32D-A306-4E81-AB38-407AFE18F27A @default.
- Q37177646 P698 Q37177646-93548C51-7494-4C45-9DE0-2F9F0C5C72A2 @default.
- Q37177646 P921 Q37177646-216BB9BA-CC21-4DF7-B549-41518380EFE9 @default.
- Q37177646 P921 Q37177646-474AB8D5-4B93-4CB2-888A-48CE6FF8942B @default.
- Q37177646 P921 Q37177646-C4334015-555A-494D-B6E2-88DEB21A23DD @default.
- Q37177646 P932 Q37177646-73254838-B05C-4D00-8381-9DF89862D32A @default.
- Q37177646 P356 BMJOPEN-2016-011857 @default.
- Q37177646 P698 27507234 @default.
- Q37177646 P1433 Q17003470 @default.
- Q37177646 P1476 "Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)." @default.
- Q37177646 P2093 "Adel H Mansur" @default.
- Q37177646 P2093 "Dinesh Saralaya" @default.
- Q37177646 P2093 "Ian Clifton" @default.
- Q37177646 P2093 "Matthew Masoli" @default.
- Q37177646 P2093 "Rekha Chaudhuri" @default.
- Q37177646 P2093 "Robert M Niven" @default.
- Q37177646 P2093 "Susan McLain-Smith" @default.
- Q37177646 P2093 "Victoria Hacking" @default.
- Q37177646 P2860 Q24201145 @default.
- Q37177646 P2860 Q24623019 @default.
- Q37177646 P2860 Q30460135 @default.
- Q37177646 P2860 Q34116185 @default.
- Q37177646 P2860 Q34627039 @default.
- Q37177646 P2860 Q36055963 @default.
- Q37177646 P2860 Q36483381 @default.
- Q37177646 P2860 Q36924944 @default.
- Q37177646 P2860 Q37428213 @default.
- Q37177646 P2860 Q37446357 @default.
- Q37177646 P2860 Q37602676 @default.
- Q37177646 P2860 Q37778663 @default.
- Q37177646 P2860 Q38118606 @default.
- Q37177646 P2860 Q38165310 @default.
- Q37177646 P2860 Q38171268 @default.
- Q37177646 P2860 Q42637412 @default.
- Q37177646 P2860 Q42693253 @default.